Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
ESSA Pharma ( (EPIX) ) has shared an update.
ESSA Pharma Inc. has introduced a new Severance Plan, replacing previous cash severance benefits for certain executive officers. This plan offers cash severance ranging from 1 to 1.5 times an officer’s base salary, with additional compensation for the CEO, tied to events like a Change in Control. The plan aims to retain key executives by providing economic security in case of qualifying terminations, ensuring stability and encouraging dedication to the company’s growth.
Find detailed analytics on EPIX stock on TipRanks’ Stock Analysis page.